-α

Anitha Elango1, Iyanar Kannan2, Ramya Ravichandar3

  • 1Department of Pharmacology, Panimalar Medical College Hospital and Research Institute, Chennai.

Bioinformation
|September 23, 2024
PubMed
概括

研究人员探索了imeglimin衍生物作为雌激素受体α阳性乳腺癌的潜在治疗方法. 五种衍生品显示出有前途的结合性和药理动力学特征,表明了新的抗癌潜力.